Login / Signup

Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE.

Josephine GrafUlrich-Frank PapeHenning JannTimm DeneckeRuza ArsenicWinfried BrennerMarianne PavelVikas Prasad
Published in: European journal of nuclear medicine and molecular imaging (2019)
Visual assessment of SSTR heterogeneity has both predictive and prognostic value in progressive grade 1 or grade 2 NET patients undergoing PRRT.
Keyphrases
  • pet ct
  • patients undergoing
  • multiple sclerosis
  • single cell
  • neuroendocrine tumors
  • binding protein
  • newly diagnosed